Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination
- 830 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination
About This Book
Autoimmunity, COVID-19, Post-COVID-19 Syndrome and COVID-19 Vaccination covers all aspects of what is perhaps the most dramatic health crisis in the history of modern medicine. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) raised major concerns about the association between the virus and various autoimmune manifestations. Over 15 distinct autoantibodies and above 10 different autoimmune diseases were found to develop in COVID-19 patients. Moreover, evidence about recovered COVID-19 patients demonstrates that persistent systemic symptoms, which are believed to have an autoimmune-related mechanism, do exist.
As it is of great importance to recognize those autoimmune manifestations of COVID-19 and post-COVID-19 syndrome to properly cope with their outcomes in the ongoing pandemic and the long-term post-pandemic period, this book fulfills a vital need in the medical community.
- Describe the short and long impact of COVID-19 on autoimmunity
- Provides understanding to the acute and chronic impact of the SARS-CoV-2
- Gives insights into the long-term effects of COVID-19 on recovered patients
- Provides conclusions on the novel terms "chronic post-COVID-19 syndrome", "post-acute COVID-19 syndrome", and "long COVID-19"
Frequently asked questions
Information
Table of contents
- Cover image
- Title page
- Table of Contents
- Copyright
- List of contributors
- About the editors
- Foreword
- Preface
- Chapter 1. Setting a context for autoantibodies, autoimmunity, and autoimmune diseases associated with SARS-CoV2
- Chapter 2. The mosaic of autoimmunity and autoinflammation and SARS-CoV-2 as an environmental factor
- Chapter 3. Innate immune responses in COVID-19
- Chapter 4. The role of TĀ cell immunity in COVID-19
- Chapter 5. Laboratory characteristics of cytokine storm syndrome in COVID-19 infection
- Chapter 6. COVID-19: the impact of the cytokineĀ storm on the immune-neuroendocrine system
- Chapter 7. Genetic predisposition to COVID-19 and post-COVID syndrome
- Chapter 8. Molecular mimicry and SARS-CoV-2
- Chapter 9. In silico study of molecular mimicry between SARS-CoV-2 and neutrophil extracellular traps composition in granulocyte-rich supernatants of patients with systemic lupus erythematosus and lupus nephritis
- Chapter 10. COVID-19 and the hyperferritinemic syndromes
- Chapter 11. SARS-CoV-2 and microbiome: pathology, implications and therapeutic options
- Chapter 12. Molecular and immunological evidence for SARS-CoV-2 being the autoimmune virus
- Chapter 13. Autoantibodies neutralizing antiinflammatory mediators in the context of SARS-CoV-2 infection and COVID-19
- Chapter 14. What is common to MDA5 and COVID-19?
- Chapter 15. Humoral immunity and thrombosis in COVID-19
- Chapter 16. Peripheral nervous system manifestations associated with COVID-19
- Chapter 17. Central nervous system impairments in COVID-19
- Chapter 18. Neuropsychiatric side of the COVID-19
- Chapter 19. Myocarditis following vaccination with Pfizer-BioNTech BNT162b2 against coronavirus infection (COVID-19)
- Chapter 20. Rheumatic manifestations and autoimmunity associated with COVID-19
- Chapter 21. SARS-CoV-2 induction and COVID-19 manifestations related to autoimmune gastrointestinal diseases
- Chapter 22. Multisystem inflammatory syndrome in children
- Chapter 23. Anosmia in COVID-19 and post-COVID syndrome
- Chapter 24. The effect of COVID-19 on patients with preexisting autoimmune diseases
- Chapter 25. COVID-19 in patients with Systemic Lupus Erythematosus and the antiphospholipid syndrome
- Chapter 26. Psoriatic arthritis and psoriasis in the era of COVID-19
- Chapter 27. Thyroid autoimmunity and COVID-19
- Chapter 28. Variation of the COVID-19 characteristics between genders
- Chapter 29. SARS-CoV-2, fertility-related autoantibodies and reproductive injury
- Chapter 30. Maternal and fetal issues in COVID-19-mediated thromboinflammation
- Chapter 31. Animal models of COVID-19 and complications
- Chapter 32. Risk assessment for aerosol infection by SARS-CoV-2 and protection by respirators and surgical masks
- Chapter 33. Therapeutic options in COVID-19
- Chapter 34. Intravenous immunoglobulin and convalescent plasma treatment in the COVID-19 patient
- Chapter 35. Interaction between vitamin D deficiency and COVID-19
- Chapter 36. Side effects of the COVID-19 vaccines
- Chapter 37. The post-COVID syndrome
- Chapter 38. Disease course and pathogenesis of post-COVID-19 condition
- Chapter 39. Long-term assessment of autoantibodies in post-COVID syndrome
- Chapter 40. Post-COVID-19 syndrome and fibromyalgia
- Chapter 41. Treatment and prevention of the post-COVID syndrome
- Index